Active, not recruitingNCT06733337

A Study to Learn About the Safety of TALZENNA in People With Prostate Cancer.

Studying Cap myopathy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Pfizer
Principal Investigator
Pfizer CT.gov Call Center
Pfizer
Enrollment
1 enrolled
Eligibility
0 years · MALE
Timeline
20252029

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06733337 on ClinicalTrials.gov

Other trials for Cap myopathy

Additional recruiting or active studies for the same condition.

See all trials for Cap myopathy

← Back to all trials